Going from technology to biology to fix babies' hearts

Clinicians at the Mayo Clinic and Boston Children's Hospital are among those attempting to harness the body's own regenerative power to treat babies born with one ventricle, a condition known as hypoplastic left heart syndrome. Surgical advances over the past three decades have enabled some children with the condition to survive, but many others do not. At Boston Children's, blood flow is being surgically restored to the left ventricle in an effort to spur regeneration, while teams at Mayo are using the babies' umbilical-cord blood cells to strengthen the right ventricle enough to compensate for loss of the left.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY